BW Communities

author-image

C H Unnikrishnan

Author

Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals. 

Latest Articles By C H Unnikrishnan

Serving And Caring At Home

By bringing care services to the doorstep, Care24 is slowly becoming an integral part of the healthcare sector

Read More
Mahindra & Mahindra: Carving A New Path

Mahindra & Mahindra’s new customer centric philosophy has yielded smart dividends

Read More
Back In The Game

Armed with new strategies and a 10,000-electric car deal, Tata Motors is reclaiming its place

Read More
Disrupt And Grow

With Jio, GenNext Hub and now Reliance Retail, RIL has shown why it is the king of disruptions

Read More
Mahindra Holidays Plans Inventory Build-Up, New Products To Optimise Returns, Ward Off Risks

The new projects to increase the room capacity include those at Goa (250 rooms), Ashtamudi (100 rooms), Kandhaghat (150 rooms) and Naldehera (110 rooms)

Read More
Down The Tech’s Rabbit Hole

How B-Schools are slowly but surely gearing up to redesign management education to meet tomorrow’s tech challenges

Read More
Mahindra Lifespace Enters Sustainable Industrial Cluster Space

The company says it is exploring similar opportunities across the country and is in the process of identifying locations

Read More
Corporate: Ripples Of That Shock

Corporate India has not quite recovered from that sudden jolt to sales in November 2016. The worst hit were manufacturers of domestic appliances, consumer electronics and food products

Read More
Genomics: Cracking The Code

Why only a handful of new-gen startups are venturing into the genomics research landscape in India

Read More
Need To Create Better Ecosystem For Genomics In India: MedGenome Founder

The government's strategy is to increase India's total biotech revenues to $100 billion by 2025, which is more than tenfold since the biotech industry started up here about two decades ago

Read More

Subscribe to our newsletter to get updates on our latest news